|
1
|
Clark JC, Dass CR and Choong PF: A review
of clinical and molecular prognostic factors in osteosarcoma. J
Cancer Res Clin Oncol. 134:281–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu H, Li W, Zhang M, Zhu S, Zhang D and
Wang X: Inhibitory roles of miR-320 in osteosarcoma via regulating
E2F1. J Cancer Res Ther. 12:68–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qureshi A, Ahmad Z, Azam M and Idrees R:
Epidemiological data for common bone sarcomas. Asian Pac J Cancer
Prev. 11:393–395. 2010.PubMed/NCBI
|
|
4
|
Baldauf C, Jeschke A, Kanbach V,
Catala-Lehnen P, Baumhoer D, Gerull H, Buhs S, Amling M, Nollau P,
Harroch S and Schinke T: The protein tyrosine phosphatase Rptpζ
suppresses osteosarcoma development in Trp53-heterozygous mice.
PLoS One. 10:e01377452015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fromigué O, Haÿ E, Modrowski D, Bouvet S,
Jacquel A, Auberger P and Marie PJ: RhoA GTPase inactivation by
statins induces osteosarcoma cell apoptosis by inhibiting
p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell
differentiation. Cell Death Differ. 13:1845–1856. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kansara M, Teng MW, Smyth MJ and Thomas
DM: Translational biology of osteosarcoma. Nat Rev Cancer.
14:722–735. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kansara M, Tsang M, Kodjabachian L, Sims
NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons
PJ, et al: Wnt inhibitory factor 1 is epigenetically silenced in
human osteosarcoma, and targeted disruption accelerates
osteosarcomagenesis in mice. J Clin Invest. 119:837–851. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kuijjer ML, Rydbeck H, Kresse SH, Buddingh
EP, Lid AB, Roelofs H, Bürger H, Myklebost O, Hogendoorn PC,
Meza-Zepeda LA and Cleton-Jansen AM: Identification of osteosarcoma
driver genes by integrative analysis of copy number and gene
expression data. Genes Chromosomes Cancer. 51:696–706. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sadikovic B, Yoshimoto M, Chilton-MacNeill
S, Thorner P, Squire JA and Zielenska M: Identification of
interactive networks of gene expression associated with
osteosarcoma oncogenesis by integrated molecular profiling. Hum Mol
Genet. 18:1962–1975. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Okamoto O, Hozumi K, Katagiri F, Takahashi
N, Sumiyoshi H, Matsuo N, Yoshioka H, Nomizu M and Fujiwara S:
Dermatopontin promotes epidermal keratinocyte adhesion via
alpha3beta1 integrin and a proteoglycan receptor. Biochemistry.
49:147–155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Markway BD, Cho H, Anderson DE, Holden P,
Ravi V, Little CB and Johnstone B: Reoxygenation enhances tumour
necrosis factor alpha-induced degradation of the extracellular
matrix produced by chondrogenic cells. Eur Cell Mater. 31:425–439.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu H, Liu S, Zhang G, Kwong LN, Zhu Y,
Miller JP, Hu Y, Zhong W, Zeng J, Wu L, et al: Oncogenic
BRAF-mediated melanoma cell invasion. Cell Rep. 15:2012–2024. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamatoji M, Kasamatsu A, Kouzu Y, Koike H,
Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K:
Dermatopontin: A potential predictor for metastasis of human oral
cancer. Int J Cancer. 130:2903–2911. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu Y, Feng MX, Yu J, Ma MZ, Liu XJ, Li J,
Yang XM, Wang YH, Zhang YL, Ao JP, et al: DNA methylation-mediated
silencing of matricellular protein dermatopontin promotes
hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase
signaling. Oncotarget. 5:6701–6715. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuroda K, Okamoto O and Shinkai H:
Dermatopontin expression is decreased in hypertrophic scar and
systemic sclerosis skin fibroblasts and is regulated by
transforming growth factor-beta1, interleukin-4, and matrix
collagen. J Invest Dermatol. 112:706–710. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Catherino WH, Leppert PC, Stenmark MH,
Payson M, Potlog-Nahari C, Nieman LK and Segars JH: Reduced
dermatopontin expression is a molecular link between uterine
leiomyomas and keloids. Genes Chromosomes Cancer. 40:204–217. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Russell SB, Russell JD, Trupin KM, Gayden
AE, Opalenik SR, Nanney LB, Broquist AH, Raju L and Williams SM:
Epigenetically altered wound healing in keloid fibroblasts. J
Invest Dermatol. 130:2489–2496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takeuchi T, Suzuki M, Kumagai J, Kamijo T,
Sakai M and Kitamura T: Extracellular matrix dermatopontin
modulates prostate cell growth in vivo. J Endocrinol. 190:351–361.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bacci G, Bertoni F, Longhi A, Ferrari S,
Forni C, Biagini R, Bacchini P, Donati D, Manfrini M, Bernini G and
Lari S: Neoadjuvant chemotherapy for high-grade central
osteosarcoma of the extremity. Histologic response to preoperative
chemotherapy correlates with histologic subtype of the tumor.
Cancer. 97:3068–3075. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Allison DC, Carney SC, Ahlmann ER,
Hendifar A, Chawla S, Fedenko A, Angeles C and Menendez LR: A
meta-analysis of osteosarcoma outcomes in the modern medical era.
Sarcoma. 2012:7048722012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xin M, Qiao Z, Li J, Liu J, Song S, Zhao
X, Miao P, Tang T, Wang L, Liu W, et al: miR-22 inhibits tumor
growth and metastasis by targeting ATP citrate lyase: Evidence in
osteosarcoma, prostate cancer, cervical cancer and lung cancer.
Oncotarget. 7:44252–44265. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng S, Zhang X, Huang N, Qiu Q, Jin Y
and Jiang D: Down-regulation of S100A9 inhibits osteosarcoma cell
growth through inactivating MAPK and NF-κB signaling pathways. BMC
Cancer. 16:2532016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Neame PJ, Choi HU and Rosenberg LC: The
isolation and primary structure of a 22-kDa extracellular matrix
protein from bovine skin. J Biol Chem. 264:5474–5479.
1989.PubMed/NCBI
|
|
24
|
Tracy LE, Minasian RA and Caterson EJ:
Extracellular matrix and dermal fibroblast function in the healing
wound. Adv Wound Care (New Rochelle). 5:119–136. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kato A, Okamoto O, Ishikawa K, Sumiyoshi
H, Matsuo N, Yoshioka H, Nomizu M, Shimada T and Fujiwara S:
Dermatopontin interacts with fibronectin, promotes fibronectin
fibril formation, and enhances cell adhesion. J Biol Chem.
286:14861–14869. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Riquelme C, Larrain J, Schonherr E,
Henriquez JP, Kresse H and Brandan E: Antisense inhibition of
decorin expression in myoblasts decreases cell responsiveness to
transforming growth factor beta and accelerates skeletal muscle
differentiation. J Biol Chem. 276:3589–3596. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dudás J, Kovalszky I, Gallai M, Nagy JO,
Schaff Z, Knittel T, Mehde M, Neubauer K, Szalay F and Ramadori G:
Expression of decorin, transforming growth factor-beta 1, tissue
inhibitor metalloproteinase 1 and 2, and type IV collagenases in
chronic hepatitis. Am J Clin Pathol. 115:725–735. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Costacurta A, Priante G, D'Angelo A,
Chieco-Bianchi L and Cantaro S: Decorin transfection in human
mesangial cells downregulates genes playing a role in the
progression of fibrosis. J Clin Lab Anal. 16:178–186. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang S, Yang JH, Guo CK and Cai PC: Gene
silencing of TKTL1 by RNAi inhibits cell proliferation in human
hepatoma cells. Cancer Lett. 253:108–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Krishnaswamy VR and Korrapati PS: Role of
dermatopontin in re-epithelialization: Implications on keratinocyte
migration and proliferation. Sci Rep. 4:73852014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kato A, Okamoto O, Wu W, Matsuo N, Kumai
J, Yamada Y, Katagiri F, Nomizu M and Fujiwara S: Identification of
fibronectin binding sites in dermatopontin and their biological
function. J Dermatol Sci. 76:51–59. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Behnam K, Murray SS and Brochmann EJ: BMP
stimulation of alkaline phosphatase activity in pluripotent mouse
C2C12 cells is inhibited by dermatopontin, one of the most abundant
low molecular weight proteins in demineralized bone matrix. Connect
Tissue Res. 47:271–277. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fernald K and Kurokawa M: Evading
apoptosis in cancer. Trends Cell Biol. 23:620–633. 2013. View Article : Google Scholar : PubMed/NCBI
|
